Darrow Company’s CVS Health CVS Stock Holding History

Darrow Company’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-242	Closed	-$22K	–	36
2022 Q2	$22K	Buy	+242	New	+$23.6K	0.02%	55

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Darrow Company's CVS Position: Q3 2022 in Review

Darrow Company sold out of CVS Health (CVS) in Q3 2022, closing a stake of 242 shares — an estimated $22K sold.

Darrow Company first reported a position in CVS in Q2 2022 and held it in 1 quarter. The position peaked at $22K in Q2 2022. 2,325 funds tracked by Wall St. Rank hold CVS as of Q3 2022.

Darrow Company reported no remaining CVS Health position as of Q3 2022 after selling out during the quarter.
Darrow Company sold 242 CVS Health shares in Q3 2022, an estimated $22K.
Darrow Company first reported a position in CVS Health in Q2 2022 and held it in 1 quarter.
Darrow Company's CVS Health position peaked at $22K in Q2 2022.
2,325 funds tracked by Wall St. Rank held CVS Health as of Q3 2022.

Based on Darrow Company's 13F filing for Q3 2022, filed 3 Nov 2022.